Genex Financial Statements From 2010 to 2025
| GENX Stock | USD 0.0001 0.00 0.00% |
Check Genex Pharmaceutical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Genex Pharmaceutical's main balance sheet or income statement drivers, such as , as well as many indicators such as . Genex financial statements analysis is a perfect complement when working with Genex Pharmaceutical Valuation or Volatility modules.
Genex |
Genex Pharmaceutical Company Profit Margin Analysis
Genex Pharmaceutical's Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Current Genex Pharmaceutical Profit Margin | 0.11 % |
Most of Genex Pharmaceutical's fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Genex Pharmaceutical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
| Competition |
Based on the latest financial disclosure, Genex Pharmaceutical has a Profit Margin of 0.1058%. This is 100.94% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The profit margin for all United States stocks is 108.33% lower than that of the firm.
Genex Pharmaceutical Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Genex Pharmaceutical's current stock value. Our valuation model uses many indicators to compare Genex Pharmaceutical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Genex Pharmaceutical competition to find correlations between indicators driving Genex Pharmaceutical's intrinsic value. More Info.Genex Pharmaceutical is one of the top stocks in return on equity category among its peers. It also is one of the top stocks in return on asset category among its peers reporting about 0.52 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Genex Pharmaceutical is roughly 1.92 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Genex Pharmaceutical by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Genex Pharmaceutical's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.About Genex Pharmaceutical Financial Statements
Genex Pharmaceutical investors use historical fundamental indicators, such as Genex Pharmaceutical's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Genex Pharmaceutical. Please read more on our technical analysis and fundamental analysis pages.
Genex Pharmaceutical, Inc. produces and distributes Reconstituted Bone Xenograft in the Peoples Republic of China. Genex Pharmaceutical is headquartered in Tianjin City, the Peoples Republic of China. Genex Pharmaceutical operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 86 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Genex Pink Sheet Analysis
When running Genex Pharmaceutical's price analysis, check to measure Genex Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genex Pharmaceutical is operating at the current time. Most of Genex Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Genex Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genex Pharmaceutical's price. Additionally, you may evaluate how the addition of Genex Pharmaceutical to your portfolios can decrease your overall portfolio volatility.